CASI CASI Pharmaceuticals, Inc.: שולי רווח תפעולי ממכירות

לוגו של חברה ציבורית casipharmaceuticals.com (CASI)

Intense patent battles in oncohematology and the risk of displacement by new therapy methods drive the volatility of CASI Pharmaceuticals (CASI). Core business profit margins confirm this pressure, with the indicator holding at 0.00. Stability is maintained through production outsourcing to CDMO plants and a moderate balance between US and Chinese regulators in the humanitarian sector.

CASI Pharmaceuticals Inc. (CASI): שולי הרווח התפעולי מ-04.07.2022 עד 14.03.2026

פילוחים אנליטיים ודוחות נתונים של חברת CASI Pharmaceuticals, Inc (CASI)

הערכת שווי פונדמנטלית של החברה:CASI, CASI Pharmaceuticals Inc.
מוצרים מוגמרים של CASI Pharmaceuticals Inc.

This indicator measures the share of operating profit in revenue, reflecting management's ability to control costs before accounting for financial leverage and taxes. For CASI Pharmaceuticals, this metric demonstrates the efficiency of commercializing Western oncology drugs in China, while the historical operating margin allows for the timely recognition of business model degradation and the avoidance of a value trap.